Zexian Liu

25.2k total citations · 4 hit papers
181 papers, 7.8k citations indexed

About

Zexian Liu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Zexian Liu has authored 181 papers receiving a total of 7.8k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Molecular Biology, 41 papers in Cancer Research and 37 papers in Oncology. Recurrent topics in Zexian Liu's work include RNA modifications and cancer (28 papers), Advanced Optimization Algorithms Research (23 papers) and Cancer-related molecular mechanisms research (22 papers). Zexian Liu is often cited by papers focused on RNA modifications and cancer (28 papers), Advanced Optimization Algorithms Research (23 papers) and Cancer-related molecular mechanisms research (22 papers). Zexian Liu collaborates with scholars based in China, United States and Hong Kong. Zexian Liu's co-authors include Yu Xue, Han Cheng, Yongbo Wang, Jian Ren, Wankun Deng, Qi Zhao, Rui‐Hua Xu, Huai‐Qiang Ju, Xinjiao Gao and Hongwei Liu and has published in prestigious journals such as Nucleic Acids Research, Advanced Materials and Nature Communications.

In The Last Decade

Zexian Liu

170 papers receiving 7.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

HemI: A Toolkit for Illustrating Heatmaps

2014 863 citations Zexian Liu, Han Cheng et al. profile →
LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer

2019 374 citations Yun Wang, Qi-Nian Wu et al. profile →
Evaluation of POLE and POLD1 Mutations as Biomarkers for Immunotherapy Outcomes Across Multiple Cancer Types

2019 280 citations Feng Wang, Qi Zhao et al. profile →
Phosphorylated NFS1 weakens oxaliplatin-based chemosensitivity of colorectal cancer by preventing PANoptosis

2022 226 citations Peishan Hu, Kai Yu et al. profile →

Peers

Countries citing papers authored by Zexian Liu

Since Specialization

Citations

This map shows the geographic impact of Zexian Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zexian Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zexian Liu more than expected).

Fields of papers citing papers by Zexian Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zexian Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zexian Liu. The network helps show where Zexian Liu may publish in the future.

Co-authorship network of co-authors of Zexian Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Zexian Liu. A scholar is included among the top collaborators of Zexian Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zexian Liu. Zexian Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Proline rich-39 (PR-39) antimicrobial protein alleviated lipopolysaccharide-induced intestinal barrier dysfunction in piglets by altering intestinal flora associated bile acid metabolism and in turn regulating TGR-5/NF-κB/MLCK/MLC pathway 2025 ·International Journal of Biological Macromolecules ·Zhineng Liu, (unknown), Bin Zhang, (unknown), (unknown), Zheng Yang, (unknown), Zexian Liu, (unknown), Xuemei Wang, (unknown), Haiwen Zhang	1
2	Construction of exosome non-coding RNA feature for non-invasive, early detection of gastric cancer patients by machine learning: a multi-cohort study 2025 ·Gut ·Zerong Cai, Yongqiang Zheng, Yan Hu, Mengyao Ma, Yijin Wu, Jia Liu, Lu-Ping Yang, Jia‐Bo Zheng, Tian Tian, Peishan Hu, Zexian Liu, (unknown), (unknown), Huai‐Qiang Ju	12
3	The liver microenvironment orchestrates FGL1-mediated immune escape and progression of metastatic colorectal cancer 2023 ·Nature Communications ·(unknown), (unknown), Tian Tian, (unknown), Yongqiang Zheng, Hai‐Yu Mo, Hui Sheng, Yan‐Xing Chen, Qi‐Nian Wu, Yi Han, Kun Liao, (unknown), Zhao-Lei Zeng, Zexian Liu, (unknown), Rui‐Hua Xu, Huai‐Qiang Ju	44
4	A regularized limited memory subspace minimization conjugate gradient method for unconstrained optimization 2023 ·Numerical Algorithms ·(unknown), Hongwei Liu, Zexian Liu	1
5	Residual circulating tumor DNA after adjuvant chemotherapy effectively predicts recurrence of stage II‐III gastric cancer 2023 ·Cancer Communications ·Shuqiang Yuan, Run‐Cong Nie, (unknown), Yingbo Chen, Siyu Wang, Xiaowei Sun, Yuanfang Li, (unknown), Yan‐Xing Chen, (unknown), Yu Kang T. Xu, Haibo Qiu, (unknown), Wei Wang, Zexian Liu, Qi Zhao, Rui‐Hua Xu, Zhiwei Zhou, Feng Wang	13
6	A New Subspace Minimization Conjugate Gradient Method for Unconstrained Minimization 2023 ·Journal of Optimization Theory and Applications ·Zexian Liu, (unknown), Hongwei Liu, (unknown)	2
7	Anatomic zone division and clinical significance of the lumbar sinuvertebral nerves 2023 ·The Spine Journal ·Junjie Chen, Zexian Liu, (unknown), Zezheng Liu, (unknown), Zhenfeng Zhang, (unknown), Qingchu Li, Qinghao Zhao	4
8	Long noncoding RNA Regulating ImMune Escape regulates mixed lineage leukaemia protein‐1‐H3K4me3‐mediated immune escape in oesophageal squamous cell carcinoma 2023 ·Clinical and Translational Medicine ·Jia Liu, (unknown), Xiaojing Luo, Yan‐Xing Chen, Chau‐Wei Wong, Zexian Liu, Jia‐Bo Zheng, (unknown), (unknown), Jiajun Li, Ming Zhong, (unknown), Qihua Zhang, Heng‐Ying Pu, Qi‐Nian Wu, Ying Jin, Zixian Wang, Rui‐Hua Xu, Hui Luo	30
9	CircVPS13C promotes pituitary adenoma growth by decreasing the stability of IFITM1 mRNA via interacting with RRBP1 2022 ·Oncogene ·Weiyu Zhang, Siyu Chen, Qiu Du, (unknown), Yutong Chen, Zexian Liu, Jian Zheng, Ke Sai, Yonggao Mou, Zhongping Chen, (unknown), Xiaobing Jiang	19
10	A novel protein RASON encoded by a lncRNA controls oncogenic RAS signaling in KRAS mutant cancers 2022 ·Cell Research ·Rongjie Cheng, Fanying Li, Maolei Zhang, Xin Xia, (unknown), Xinya Gao, Huangkai Zhou, Zhi Zhang, Nunu Huang, Xuesong Yang, Yaliang Zhang, Shunli Shen, Tiebang Kang, Zexian Liu, Feizhe Xiao, Hongwei Yao, Jianbo Xu, Chao Yan, Nu Zhang	40
11	iHypoxia: An Integrative Database of Protein Expression Dynamics in Response to Hypoxia in Animals 2022 ·Genomics Proteomics & Bioinformatics ·Zexian Liu, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Tian Shao, (unknown), Han Cheng, Zhenlong Wang	3
12	MYC-Activated LncRNA MNX1-AS1 Promotes the Progression of Colorectal Cancer by Stabilizing YB1 2021 ·Cancer Research ·Qi‐Nian Wu, Xiao-Jing Luo, Jia Liu, Yun‐Xin Lu, Yun Wang, Jingjing Qi, Zexian Liu, Qitao Huang, Ze-Kun Liu, Jiabin Lu, Ying Jin, Heng‐Ying Pu, Peishan Hu, Jia‐Bo Zheng, Zhao-Lei Zeng, Huai‐Qiang Ju, Dan Xie, Qi Zhao, Rui‐Hua Xu	59
13	Preparation of Slow-Release Insecticides from Biogas Slurry: Effectiveness of Ion Exchange Resin in the Adsorption and Release of Ammonia Nitrogen 2021 ·Processes ·Quanguo Zhang, Zexian Liu, Francesco Petracchini, Chaoyang Lu, Yameng Li, Zhiping Zhang, Valerio Paolini, Huan Zhang	4
14	iCAV: an integrative database of cancer-associated viruses 2021 ·Database ·Bo Liu, Qingfeng Zhang, (unknown), (unknown), Zhiyuan Zhou, Zexian Liu, Han Cheng	3
15	Multiomics analysis of tumor mutational burden across cancer types 2021 ·Computational and Structural Biotechnology Journal ·Lin Li, Long Bai, Huan Lin, (unknown), Rumeng Zhang, Xiao Cheng, Zexian Liu, Yi Ouyang, Keshuo Ding	19
16	Systematic Analysis of the Aberrances and Functional Implications of Ferroptosis in Cancer 2020 ·iScience ·Zekun Liu, Qi Zhao, Zhixiang Zuo, Shuqiang Yuan, Kai Yu, Qingfeng Zhang, Xiao-Long Zhang, Hui Sheng, Huai‐Qiang Ju, Han Cheng, Feng Wang, Rui‐Hua Xu, Zexian Liu	163
17	Ubiquitinome Profiling Reveals the Landscape of Ubiquitination Regulation in Rice Young Panicles 2020 ·Genomics Proteomics & Bioinformatics ·Liya Zhu, Han Cheng, (unknown), Shuansuo Wang, Zhiguo Zhang, Erdong Ni, Xiangdong Fu, Chuxiong Zhuang, Zexian Liu, Hai Zhou	21
18	iCysMod: an integrative database for protein cysteine modifications in eukaryotes 2020 ·Briefings in Bioinformatics ·(unknown), Qingfeng Zhang, (unknown), (unknown), (unknown), (unknown), Tian Shao, Zexian Liu, Han Cheng, Zhenlong Wang	24
19	ME1 Regulates NADPH Homeostasis to Promote Gastric Cancer Growth and Metastasis 2018 ·Cancer Research ·Yun-Xin Lu, Huai‐Qiang Ju, Zexian Liu, Dong-liang Chen, Yun Wang, Qi Zhao, Qi-Nian Wu, Zhao-Lei Zeng, Hai-Bo Qiu, (unknown), Zhiqiang Wang, Dong-sheng Zhang, Feng Wang, Rui‐Hua Xu	95
20	GPS-PUP: computational prediction of pupylation sites in prokaryotic proteins 2011 ·Molecular BioSystems ·Zexian Liu, Qian Ma, Jun Cao, Xinjiao Gao, Jian Ren, Yu Xue	34

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact